Anti-inflammatory drugs testing

The compound 5-[5-(4-chlorophenyl)furan-2-yl]-2,3,4,5-tetrahydrofuran-2-one (F-1044, 7.85) is a nonsteroidal anti-inflammatory agent possibly acting via a ring-opened hydroxybutyric acid metabolite. To examine this hypothesis, F-1044 was submitted to extensive in vivo testing, which revealed potent activities and a unique pharmacological profile markedly different from that of acidic nonsteroidal anti-inflammatory drugs [169], These results have been interpreted to mean that part or most of the observed effects of F-... 

Thalidomide would fall into this category due to its inadequate testing but most commonly improper use refers to off-label use. Use of off-label pediatric medicines has been discussed earlier in this chapter. An example of off-label adult use is with Bromfenac (Duract), a nonsteroid anti-inflammatory drug. Duract was developed for short term therapy (<10 days) in 1997 butwith longer term, off-label, use elevated liver enzymes were evident and it was withdrawn approximately 1 year later. In its time on the market Duract generated approximately 90 million dollars in sales. 

Renal clearance of lithium is reduced about 25% by diuretics (eg, thiazides), and doses may need to be reduced by a similar amount. A similar reduction in lithium clearance has been noted with several of the newer nonsteroidal anti-inflammatory drugs that block synthesis of prostaglandins. This interaction has not been reported for either aspirin or acetaminophen. All neuroleptics tested to date, with the possible exception of clozapine and the newer atypical antipsychotics, may produce more severe extrapyramidal syndromes when combined with lithium. 

Ring-constrained analogues 37 of the anti-inflammatory drug, diclofenac, have been prepared by acid-catalyzed condensation of aldehydes (or ethylene ketals of ketones) with 36 (Equation 4) <1998MI201>. This reaction presumably proceeds via intramolecular nucleophilic attack by the carboxylic acid group on an iminium ion intermediate from condensation of the secondary amine. Interestingly, the compounds 37 showed comparable activities to diclofenac in the formalin-induced rat paw edema test. 

The first example of process intensification at DSM is the pilot-scale test of the enzymatic production of S-ibuprofen, a nonsteroidal, anti-inflammatory drug. The molecular scheme is given in Figure 5. More details can be found in Refs. 3 and 4. 

A number of anti-inflammatory drugs have now been tested for their therapeutic efficacy in AD. For example, the steroid prednisolone, which is lipophilic, has been administered to patients with AD for up to a year but the results were disappointing. The potent non-steroidal anti-inflammatories diclofenac and indomethacin have also been tested but shown to have minimal benefit with a high frequency of side effects. Perhaps these results are not surprising as it seems likely that the inhibition of COX will have little beneficial effect on the symptoms of AD once neuronal death has occurred, as seems likely in the clinical studies in which the patients were in the advanced... 

Many factors including partition characteristics, degree of ionization, molecular size etc. influence the transport of drugs across biological membranes. Permeation of intact mucosa may also involve passive diffusion, intercellular movement, transport through pores or other mechanisms. The objective of the studies reported here was to employ the dog model to investigate these factors in a systematic and experimentally well-controlled fashion. The non-steriodal anti-inflammatory drug, diclofenac sodium, was selected as a test compound in this evaluation process. 

The urinary caffeine test is not based on assays of specific substrates and products of NAT2 ( including other metabolism pathways involving at least xanthine-oxidases), and is affected by diet habits, xanthine-oxidase inhibitors such as allopurinol (Fuchs 1999), or other drugs (Klebovitch 1995). NAT activities are affected by anti-inflammatory drugs. Of note, acetominophen is an inhibitor of NAT2 in vivo (Rothen 1998). 

If the pharmacological properties of a test compound indicate it has the potential to affect immune function (e.g. anti-inflammatory drugs). If the majority of the patient population for whom the drug is intended... 

The concept of using anionic nanosized emulsion vehicles for enhanced percutaneous absorption of nonsteroidal anti-inflammatory drugs (NSAIDs) and diazepam was clearly proven [189, 190], NSAIDs and diazepam in a nanosized emulsion vehicle also demonstrated noticeable systemic activity. The o/w emulsion was tested for primary irritation in humans in a 48-h trial. Low irritancy and excellent human acceptance were observed, subsequently making the further development of a nanosized emulsion vehicle very attractive. 

Another important substance in hemorrhoidal formulations is bufexamac, a non-steroidal anti-inflammatory drug that is a well-known sensitizer and sometimes elicits severe dermatitis (22). Bufexamac should therefore always be included in patch tests for anogenital dermatitis. 

PrzybiUa B, Schwab-Przybilla U, Ruzicka T, Ring J. Phototoxicity of non-steroidal anti-inflammatory drugs demonstrated in vitro by a photo-basophil-histamine-release test. Photodermatol 1987 4(2) 73-8. 

---